Atlas Trials

Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

Clinical trial NCT06536309 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06536309
Sponsor
Brigham and Women's Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure With Preserved Ejection FractionMyocardial Fibrosis
Start date
2026-07-01
Primary completion
2028-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.